Bionorica SE: Bionorica adds fourth Executive Board division - Pharmacist Dr Hanke Wohlers to become Director of Product Supply

Dow Jones received a payment from EQS/DGAP to publish this press release.

DGAP-Media / 2019-01-02 / 11:04 
 
*Neumarkt in der Oberpfalz, 2 January 2019 - *On 1 January 2019 Bionorica SE 
strengthened its management team with the assignment of Dr Hanke Wohlers as 
Director of Product Supply. 'Dr Hanke Wohlers advanced us and his unit 
significantly. Moreover he enables Bionorica to reach the high growth 
targets on the production side', says Professor Dr Michael A Popp, Chairman 
of the Executive Board at Bionorica SE. The global demand for evidence-based 
herbal remedies is high. 'Over the last two years as Manager of Product 
Supply, Dr Wohlers has successfully demonstrated his deep understanding of 
the optimization of production processes', stresses Professor Popp.Dr 
Wohlers replies: 'The trust placed in me and the assignment to the Executive 
Board fills me with great pride. I would also like to thank my team; 
together we have already accomplished a lot.' In 2019 focus will be placed 
on internationalisation, the new Bionorica factory in Woronesch and lean 
management, according to the 53-year-old. 
The newly created fourth Executive Board division of 'Product Supply' has a 
staff of 420 working in the main departments of Engineering, Production, 
Supply Chain and Quality Control as well as the Qualified Persons and 
Operational Excellence (OPEX) administrative departments. Previously, these 
were organised at Bionorica SE under the 'Chairman of the Executive Board' 
Executive Board function held by Professor Popp which still encompasses such 
areas as Research and Development, Product Development & Maintenance and 
Drug Regulatory Affairs. As Head of Global Business, Dr Uwe Baumann is 
responsible for global marketing and sales; Dr Michael Rödel is Director of 
Finance, HR and IT. 
 
*From laboratory to factory manager* 
Dr Wohlers came to Bionorica in December 2016 as Manager of Product Supply. 
From 2014 to 2016 he was factory manager and managing director of the 
Troisdorf and Cologne production locations of a contract pharmaceutical 
manufacturer. During his 25-year career in the pharmaceutical industry Dr 
Wohlers also held the position as laboratory manager for development of 
analytical methods and stability testing (1994-98) at the pharmaceutical 
company. Before that he studied pharmacy at Philipps-Universität Marburg. 
Wohlers earned his Doctor of Science at the Kiel University (CAU). His 
doctoral thesis was about the topic of biotransformation of organic 
compounds by liver cells and microsomes. 
 
*Corporate profile* 
Patients want effective and tolerable medications and so herbal medicines 
are the preferred option. Bionorica with headquarters in Neumarkt in der 
Oberpfalz (Upper Palatinate), Germany, is the world's leading manufacturer 
of scientifically researched plant-based medicines. Doctors, pharmacists and 
patients in more than 40 countries trust in our effective products with few 
side effects. In 2017 Bionorica SE achieved 296.9 million euros in turnover. 
The company's equity ratio is nearly 79 per cent. More than 1,600 employees 
at 20 Bionorica locations around the world are working on a daily basis to 
continue the success story which began 86 years ago in Nuremberg, Germany. 
Based on the 'phytoneering' strategy, Bionorica decodes the extensive active 
ingredient potential of plants (phytos) using state-of-the-art research and 
technology (engineering). The result: highly effective medicines with few 
side effects. Our research and development priorities involve the treatment 
of symptoms in the respiratory tract, urinary tract, immune system and also 
women's health. Our range also includes products for the liver and for 
treating sleep disorders. 
 
*Press Contact* 
Bionorica SE 
Lion Pfeufer 
Head of Media and Public Relations 
Kerschensteinerstrasse 11-15 
92318 Neumarkt, Germany 
Phone: [phone] 
Fax: [phone] 
Email: [e-mail] 
http://english.bionorica.de/en/service/press-media.html 
 
End of Media Release 
Additional features: 
 
Picture: http://newsfeed2.eqs.com/bionorica/761093.html [1] 
Subtitle: Dr. Hanke Wohlers ist seit 1. Januar 2019 Vorstand Product Supply 
bei der Bionorica SE. (c) Bionorica SE / Steffen Jänicke 
 
Document: http://n.eqs.com/c/fncls.ssp?u=TNIFXRJAFI [2] 
Document title: Presse release (PDF) 
 
Issuer: Bionorica SE 
 
2019-01-02 Dissemination of a Press Release, transmitted by DGAP - a service 
of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
The DGAP Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
761093 2019-01-02 
 
 
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=30897612c1c5bffa8b7997c30fc16f74&application_id=761093&site_id=vwd&application_name=news 
2: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=69e069563531482843cd25424edb81bb&application_id=761093&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

January 02, 2019 05:04 ET (10:04 GMT)